Aktis Oncology, Inc. (AKTS)

Aktis Oncology Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	5.91

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$73,158
Profits Per Employee	-$798,013
Employee Count	76
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aktis Oncology had revenue of $5.56 million and -$60.65 million in losses.

Revenue	5.56M
Gross Profit	5.56M
Operating Income	-72.94M
Pretax Income	-60.65M
Net Income	-60.65M
EBITDA	-76.51M
EBIT	-72.99M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $246.22 million in cash and $11.87 million in debt, giving a net cash position of $234.36 million.

Cash & Cash Equivalents	246.22M
Total Debt	11.87M
Net Cash	234.36M
Net Cash Per Share	n/a
Equity (Book Value)	-132.39M
Book Value Per Share	n/a
Working Capital	222.51M

Cash Flow

In the last 12 months, operating cash flow was -$61.69 million and capital expenditures -$7.66 million, giving a free cash flow of -$69.34 million.

Operating Cash Flow	-61.69M
Capital Expenditures	-7.66M
Free Cash Flow	-69.34M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -1,311.94% and -1,090.81%.

Gross Margin	100.00%
Operating Margin	-1,311.94%
Pretax Margin	-1,090.81%
Profit Margin	-1,090.81%
EBITDA Margin	-1,375.99%
EBIT Margin	-1,312.77%
FCF Margin	-1,247.19%

Dividends & Yields

Aktis Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a